Cargando…

Nuclear Pore Glycoprotein 62 Genetic Variant rs9523 is Associated with Clinical Outcomes of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Lung Adenocarcinoma Patients

INTRODUCTION: Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) have represented the prototype of targeted therapy in NSCLC. Patients with EGFR-mutant lung adenocarcinoma extract an extraordinary clinical benefit from EGFR-TKIs. However, the extent and duration of these respo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Park, Ji Eun, Hong, Mi Jeong, Lee, Shin Yup, Lee, Jang Hyuck, Choi, Jin Eun, Kang, Hyo-Gyoung, Do, Sook Kyung, Jeong, Ji Yun, Shin, Kyung Min, Lee, Won Kee, Choi, Sun Ha, Lee, Yong Hoon, Seo, Hye won, Yoo, Seung Soo, Lee, Jaehee, Cha, Seung Ick, Kim, Chang Ho, Park, Jae Yong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2021
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8493114/ https://www.ncbi.nlm.nih.gov/pubmed/34629889 http://dx.doi.org/10.2147/PGPM.S329055

Ejemplares similares

Genetic Variants in Histone Modification Regions Predict Clinical Outcomes of Pemetrexed Chemotherapy in Lung Adenocarcinoma
por: Lee, Yong Hoon, et al.
Publicado: (2023)

Genetic variants of NEUROD1 target genes are associated with clinical outcomes of small‐cell lung cancer patients
por: Lee, Sunwoong, et al.
Publicado: (2023)

Exonuclease 1 genetic variant is associated with clinical outcomes of pemetrexed chemotherapy in lung adenocarcinoma
por: Hong, Mi Jeong, et al.
Publicado: (2022)

Genetic variants in LKB1/AMPK/mTOR pathway are associated with clinical outcomes of chemotherapy in non‐small cell lung cancer
por: Choi, Sun Ha, et al.
Publicado: (2022)

Promoter-Specific Variants in NeuroD1 and H3K4me3 Coincident Regions and Clinical Outcomes of Small Cell Lung Cancer
por: Yoo, Seung Soo, et al.
Publicado: (2023)

Polymorphism in ASCL1 target gene DDC is associated with clinical outcomes of small cell lung cancer patients
por: Kim, Ji Hyun, et al.
Publicado: (2019)

TERT Polymorphism rs2853669 Influences on Lung Cancer Risk in the Korean Population
por: Yoo, Seung Soo, et al.
Publicado: (2015)

The effect of susceptibility variants, identified in never-smoking female lung cancer cases, on male smokers
por: Yoo, Seung Soo, et al.
Publicado: (2020)

Epigenetic readers and lung cancer: the rs2427964C>T variant of the bromodomain and extraterminal domain gene BRD3 is associated with poorer survival outcome in NSCLC
por: Lee, Jang Hyuck, et al.
Publicado: (2021)

TSC2 genetic variant and prognosis in non‐small cell lung cancer after curative surgery
por: Lee, Yong Hoon, et al.
Publicado: (2018)

Effect of genetic variation in Notch regulator DTX1 on SCLC prognosis compared with the effect on NSCLC prongosis
por: Yoo, Seung Soo, et al.
Publicado: (2020)

Expression of key regulatory genes in necroptosis and its effect on the prognosis in non-small cell lung cancer
por: Park, Ji Eun, et al.
Publicado: (2020)

Functional intronic variant of SLC5A10 affects DRG2 expression and survival outcomes of early‐stage non‐small‐cell lung cancer
por: Hong, Mi Jeong, et al.
Publicado: (2018)

Genetic variants in key necroptosis regulators predict prognosis of non‐small cell lung cancer after surgical resection
por: Lee, Jang Hyuck, et al.
Publicado: (2023)

Genetic variants in histone modification regions are associated with the prognosis of lung adenocarcinoma
por: Kang, Hyo-Gyoung, et al.
Publicado: (2021)

PD-L1 polymorphism can predict clinical outcomes of non-small cell lung cancer patients treated with first-line paclitaxel-cisplatin chemotherapy
por: Lee, Shin Yup, et al.
Publicado: (2016)

Intronic variant of EGFR is associated with GBAS expression and survival outcome of early‐stage non‐small cell lung cancer
por: Hong, Mi Jeong, et al.
Publicado: (2018)

Automated and manual microscopic analyses for leukocyte differential counts in exudative pleural effusions: Real-world disagreement and clinical application
por: Lee, Jaehee, et al.
Publicado: (2022)

Impact of immune checkpoint gene CD155 Ala67Thr and CD226 Gly307Ser polymorphisms on small cell lung cancer clinical outcome
por: Lee, Jang Hyuck, et al.
Publicado: (2021)

Clinical implication of minimal presence of solid or micropapillary subtype in early‐stage lung adenocarcinoma
por: Choi, Sun Ha, et al.
Publicado: (2020)

Replication of the results of genome-wide and candidate gene association studies on telomere length in a Korean population
por: Do, Sook Kyung, et al.
Publicado: (2015)

Genetic Variants in the Wnt Signaling Pathway Are Not Associated with Survival Outcome of Non-Small Cell Lung Cancer in a Korean Population
por: Yoo, Seung Soo, et al.
Publicado: (2016)

Functional intronic ERCC1 polymorphism from regulomeDB can predict survival in lung cancer after surgery
por: Lee, Shin Yup, et al.
Publicado: (2015)

A genetic variation in microRNA target site of ETS2 is associated with clinical outcomes of paclitaxel-cisplatin chemotherapy in non-small cell lung cancer
por: Hong, Mi Jeong, et al.
Publicado: (2016)

Etiological Distribution and Morphological Patterns of Granulomatous Pleurisy in a Tuberculosis-prevalent Country
por: Lee, Jaehee, et al.
Publicado: (2020)

The Different Effect of VEGF Polymorphisms on the Prognosis of Non-Small Cell Lung Cancer according to Tumor Histology
por: Lee, Soyeon, et al.
Publicado: (2016)

Association between polymorphisms in microRNA target sites and survival in early‐stage non‐small cell lung cancer
por: Yoo, Seung Soo, et al.
Publicado: (2017)

A Functional Polymorphism in the CHRNA3 Gene and Risk of Chronic Obstructive Pulmonary Disease in a Korean Population
por: Lee, Jae Yeon, et al.
Publicado: (2012)

Genetic polymorphisms in glycolytic pathway are associated with the prognosis of patients with early stage non-small cell lung cancer
por: Lee, Shin Yup, et al.
Publicado: (2016)

Hemoptysis as the presenting manifestation of bronchiectasis-associated hospitalization in Korea
por: Seo, Hyewon, et al.
Publicado: (2023)

Laboratory and radiological discrimination between tuberculous and malignant pleural effusions with high adenosine deaminase levels
por: Lee, Jaehee, et al.
Publicado: (2022)

Prognostic significance of genetic variants in GLUT1 in stage III non‐small cell lung cancer treated with radiotherapy
por: Kang, Min Kyu, et al.
Publicado: (2021)

Polymorphisms in mitotic checkpoint-related genes can influence survival outcomes of early-stage non-small cell lung cancer
por: Kang, Hyo Gyoung, et al.
Publicado: (2017)

Detection of Deep Vein Thrombosis by Follow-up Indirect Computed Tomography Venography after Pulmonary Embolism
por: Lee, Hye Jin, et al.
Publicado: (2018)

Relationship Between Clinical Features and Computed Tomographic Findings in Hospitalized Adult Patients With Community-Acquired Pneumonia()
por: Seo, Hyewon, et al.
Publicado: (2018)

A Panel of Genetic Polymorphism for the Prediction of Prognosis in Patients with Early Stage Non-Small Cell Lung Cancer after Surgical Resection
por: Lee, Shin Yup, et al.
Publicado: (2015)

Clinical predictors and outcomes of non-expandable lung following percutaneous catheter drainage in lung cancer patients with malignant pleural effusion
por: Kim, Chang Ho, et al.
Publicado: (2023)

Comparison of Early and Late Tuberculosis Deaths in Korea
por: Lee, Jaehee, et al.
Publicado: (2017)

RACK1 is a candidate gene associated with the prognosis of patients with early stage non-small cell lung cancer
por: Choi, Yi-Young, et al.
Publicado: (2015)

Prognostic Value of Serum Growth Differentiation Factor-15 in Patients with Chronic Obstructive Pulmonary Disease Exacerbation
por: Kim, Miyoung, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_366vikjpvc6lmind60mipci1s6